Skip to content

Comparative study for grain moxibustion combined with microneedles in the treatment of herpes zoster

Comparative study for grain moxibustion combined with microneedles in the treatment of herpes zoster

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR1900022016
Enrollment
Unknown
Registered
2019-03-20
Start date
2018-06-11
Completion date
Unknown
Last updated
2019-03-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Herpes Zoster

Interventions

Group 1:Valaciclovir
Group 2:Wheat grain moxibustion+Scalp needle
Group 3:Wheat grain moxibustion+Wrist ankle acupuncture

Sponsors

Shanghai Fourth People's Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: (1) Patients with herpes zoster who meet the diagnostic requirements of the section of Dermatology of Chinese edition 22 of Xishi Internal Medicine and the diagnostic requirements of the Criteria for Diagnostic and Therapeutic Effects of Traditional Chinese Medicine; (2) Aged 18-80 years old, male and female; (3) patients who have not received antiviral or hormone, analgesics or acupuncture treatment within 12 days of the course of disease; (4) Voluntarily participate in the experiment and sign the "informed consent".

Exclusion criteria

Exclusion criteria: (1) Patients with other dermatological or internal infectious diseases; (2) Use of antiviral or hormone or analgesic drugs outside the subject or stop other treatments for less than one month; (3) Patients with heart, liver, kidney, functional failure or psychosis; (4) Pregnant women (women of childbearing age should undergo HCG test before enrollment to confirm pregnancy status); (5) Diabetes mellitus, hemophilia and other skin wound repair ability, coagulation dysfunction.

Design outcomes

Primary

MeasureTime frame
NRS pain classification;Pain begins to remission;Pain relief;

Secondary

MeasureTime frame
Time and area of blisters;Time and area of scab formation and scab removal;Cell factor;

Countries

China

Contacts

Public ContactZheng Qiao-Ping

Yueyang Hospital of Integrated Traditional Chinese and Western Medicine

khzqp@163.com+86 13817324059

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026